• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Gilead selling Letairis to UT

Anonymous

Guest
You heard it here! Ambition finally completed and now Gilead can sell Letairis to UT, a real PAH company. Single tablet regimen on the horizon with Adcirca and Letairis. Bye bye!
 












Why would any company buy a drug with only a few years left? Why would Gilead sell a drug that keeps going up in sales year after year? Opsumit sucks, so I see no change. This thread is BS.